📣 VC round data is live. Check it out!

Limes Schlosskliniken Valuation Multiples

Discover revenue and EBITDA valuation multiples for Limes Schlosskliniken and similar public comparables like Athens Medical Centre, Suraksha Diagnostics, Monash IVF Group, Clinica Las Condes and more.

Limes Schlosskliniken Overview

About Limes Schlosskliniken

Limes Schlosskliniken AG operates mental and psychosomatic mental health clinic. It specializes in the treatment of stress disorders including depressions, Burnout Syndrome, Posttraumatic stress disorder, Anxiety / obsessive-compulsive disorder, eating disorders, personality disorders, and Somatization disorders such as chronic pain. LIMES Schlosskliniken operates in the market for high-quality private hospitals specializing in psychiatry, psychotherapy, and psychosomatics in Germany and Switzerland.


Founded

N/A

HQ

Germany

Employees

200

Financials (LTM)

Revenue: $69M
EBITDA: $18M

EV

$177M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Limes Schlosskliniken Financials

Limes Schlosskliniken reported last 12-month revenue of $69M and EBITDA of $18M.

In the same LTM period, Limes Schlosskliniken generated $18M in EBITDA and $10M in net income.

Revenue (LTM)


Limes Schlosskliniken P&L

In the most recent fiscal year, Limes Schlosskliniken reported revenue of $63M and EBITDA of $16M.

Limes Schlosskliniken is profitable as of last fiscal year, with gross margin of 85%, EBITDA margin of 25%, and net margin of 14%.

See analyst estimates for Limes Schlosskliniken
LTMLast FY202320242025202620272028
Revenue$69M$63M$43M$44M$58M
Gross Profit-$53M$39M$40M$53M
Gross Margin-85%91%92%92%
EBITDA$18M$16M$995K$8M$15M
EBITDA Margin26%25%2%19%26%
EBIT Margin19%18%(5%)11%19%
Net Profit$10M$8M$4M$4M$7M
Net Margin15%14%9%8%11%
Net Debt-$486K---

Financial data powered by Morningstar, Inc.

Limes Schlosskliniken Stock Performance

Limes Schlosskliniken has current market cap of $177M, and enterprise value of $177M.

Market Cap Evolution


Limes Schlosskliniken's stock price is $593.41.

Limes Schlosskliniken share price increased by 3.0% in the last 30 days, and by 33.9% in the last year.

Limes Schlosskliniken has an EPS (earnings per share) of $28.51.

See more trading valuation data for Limes Schlosskliniken
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$177M$177M3.1%3.0%6.9%33.9%$28.51

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Limes Schlosskliniken Valuation Multiples

Limes Schlosskliniken trades at 2.6x EV/Revenue multiple, and 9.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Limes Schlosskliniken

EV / Revenue (LTM)


Limes Schlosskliniken Financial Valuation Multiples

As of June 3, 2026, Limes Schlosskliniken has market cap of $177M and EV of $177M.

Limes Schlosskliniken has a P/E ratio of 17.4x.

LTMLast FY202320242025202620272028
EV/Revenue2.6x2.8x4.1x4.1x3.0x
EV/EBITDA9.9x11.2x178.2x21.6x11.9x
EV/EBIT13.4x15.8x(85.1x)35.5x16.4x
EV/Gross Profit-3.3x4.5x4.4x3.3x
P/E17.4x20.8x44.7x48.8x26.7x
EV/FCF17.9x37.6x(43.4x)61.4x133.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Limes Schlosskliniken Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Limes Schlosskliniken Margins & Growth Rates

Limes Schlosskliniken grew revenue by 24% and EBITDA by 31% in the last fiscal year.

In the most recent fiscal year, Limes Schlosskliniken reported gross margin of 85%, EBITDA margin of 25%, and net margin of 14%.

See estimated margins and future growth rates for Limes Schlosskliniken

Limes Schlosskliniken Margins

Last FY202420252026202720282029
Gross Margin85%92%92%-
EBITDA Margin25%19%26%27%
EBIT Margin18%11%19%21%
Net Margin14%8%11%16%
FCF Margin8%7%2%22%

Limes Schlosskliniken Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth24%1%33%33%
Gross Profit Growth-2%33%-
EBITDA Growth31%725%81%39%
EBIT Growth43%(339%)117%48%
Net Profit Growth46%(8%)83%88%
FCF Growth261%(171%)(54%)1184%

Data powered by FactSet, Inc. and Morningstar, Inc.

Limes Schlosskliniken Operational KPIs

Limes Schlosskliniken's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Limes Schlosskliniken's Rule of 40 is 60% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Limes Schlosskliniken's Rule of X is 109% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Limes Schlosskliniken
LTMLast FY202320242025202620272028
Rule of 4045%60%---
Bessemer Rule of X74%109%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.2M---
S&M Expenses to Revenue-7%7%8%7%
Opex to Revenue-68%96%81%73%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Limes Schlosskliniken Competitors

Limes Schlosskliniken competitors include Athens Medical Centre, Suraksha Diagnostics, Monash IVF Group, Clinica Las Condes, Hyperfine, Centrum Medyczne ENEL-MED, Goodwill Pharma, MediClin, Fonar and Atrys Health.

Most Limes Schlosskliniken public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Athens Medical Centre1.1x-11.0x-
Suraksha Diagnostics5.2x5.4x16.4x17.4x
Monash IVF Group1.7x1.7x7.4x7.8x
Clinica Las Condes2.7x-(5.9x)-
Hyperfine9.0x7.5x(3.5x)(3.6x)
Centrum Medyczne ENEL-MED1.0x-7.8x-
Goodwill Pharma3.0x-11.3x-
MediClin0.5x0.5x3.8x3.6x

This data is available for Pro users. Sign up to see all Limes Schlosskliniken competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Limes Schlosskliniken

Where is Limes Schlosskliniken headquartered?Limes Schlosskliniken is headquartered in Germany.
How many employees does Limes Schlosskliniken have?As of today, Limes Schlosskliniken has over 200 employees.
Is Limes Schlosskliniken publicly listed?Yes, Limes Schlosskliniken is a public company listed on Frankfurt Stock Exchange.
What is the stock symbol of Limes Schlosskliniken?Limes Schlosskliniken trades under LIK ticker.
When did Limes Schlosskliniken go public?Limes Schlosskliniken went public in 2019.
Who are competitors of Limes Schlosskliniken?Limes Schlosskliniken main competitors include Athens Medical Centre, Suraksha Diagnostics, Monash IVF Group, Clinica Las Condes, Hyperfine, Centrum Medyczne ENEL-MED, Goodwill Pharma, MediClin, Fonar, Atrys Health.
What is the current market cap of Limes Schlosskliniken?Limes Schlosskliniken's current market cap is $177M.
What is the current revenue of Limes Schlosskliniken?Limes Schlosskliniken's last 12 months revenue is $69M.
What is the current revenue growth of Limes Schlosskliniken?Limes Schlosskliniken revenue growth (NTM/LTM) is 19%.
What is the current EV/Revenue multiple of Limes Schlosskliniken?Current revenue multiple of Limes Schlosskliniken is 2.6x.
What is the current EBITDA of Limes Schlosskliniken?Limes Schlosskliniken's last 12 months EBITDA is $18M.
What is Limes Schlosskliniken's EBITDA margin?Limes Schlosskliniken's last 12 months EBITDA margin is 26%.
What is the current EV/EBITDA multiple of Limes Schlosskliniken?Current EBITDA multiple of Limes Schlosskliniken is 9.9x.
What is the current FCF of Limes Schlosskliniken?Limes Schlosskliniken's last 12 months FCF is $10M.
What is Limes Schlosskliniken's FCF margin?Limes Schlosskliniken's last 12 months FCF margin is 14%.
What is the current EV/FCF multiple of Limes Schlosskliniken?Current FCF multiple of Limes Schlosskliniken is 17.9x.
How many companies Limes Schlosskliniken has acquired to date?Limes Schlosskliniken hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Limes Schlosskliniken has invested to date?Limes Schlosskliniken hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Limes Schlosskliniken

Lists including Limes Schlosskliniken

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial